P53 mutation and LOH at chromosome 9 in urothelial carcinoma

Background: Mutation of the p53 gene has been implicated in the development of carcinoma in situ (CIS) to invasive solid urothelial carcinomas (UC) whereas loss of heterozygosity (LOH) at chromosome 9 has been suggested to plag part in the development of papillary UCs. Patients and Methods: The p53...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Beöthe, Tamás (VerfasserIn) , Nagy, Anetta (VerfasserIn) , Kovacs, Gyula (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: December 21, 2011
In: Anticancer research
Year: 2012, Jahrgang: 32, Heft: 2, Pages: 523-527
ISSN:1791-7530
Online-Zugang:Verlag, kostenfrei, Volltext: http://ar.iiarjournals.org/content/32/2/523
Volltext
Verfasserangaben:Tamas Beothe, Anetta Nagy, Laszlo Farkas, Gyula Kovacs

MARC

LEADER 00000caa a2200000 c 4500
001 1572106344
003 DE-627
005 20220814115231.0
007 cr uuu---uuuuu
008 180418s2011 xx |||||o 00| ||eng c
035 |a (DE-627)1572106344 
035 |a (DE-576)502106344 
035 |a (DE-599)BSZ502106344 
035 |a (OCoLC)1341007155 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Beöthe, Tamás  |d 1973-  |e VerfasserIn  |0 (DE-588)1156311438  |0 (DE-627)1018864024  |0 (DE-576)502100796  |4 aut 
245 1 0 |a P53 mutation and LOH at chromosome 9 in urothelial carcinoma  |c Tamas Beothe, Anetta Nagy, Laszlo Farkas, Gyula Kovacs 
264 1 |c December 21, 2011 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 18.04.2018 
520 |a Background: Mutation of the p53 gene has been implicated in the development of carcinoma in situ (CIS) to invasive solid urothelial carcinomas (UC) whereas loss of heterozygosity (LOH) at chromosome 9 has been suggested to plag part in the development of papillary UCs. Patients and Methods: The p53 mutation and LOH at chromosomes 17p13.1 and 9 were analysed in 120 UCs. Tumor and matched normal DNA were used for microsatellite allelotyping of chromosome 17p and the entire chromosome 9. Results: LOH at 17p13.1 was found in each grade and stage of the UCs, but mutation of the p53 occurred only in the highly malignant G3 tumors including papillary pT1G3 UCs. LOH were found at one or more of the seven tumor suppressor gene loci along chromosome 9 in all but two of the UCs with p53 mutation. Conclusion: Mutation of the p53 gene is not a pathway correlated genetic change, but is associated with the increased cell proliferation of G3 UCs. 
650 4 |a chromosome 17p LOH 
650 4 |a chromosome 9 LOH 
650 4 |a developmental pathway 
650 4 |a p53 mutation 
650 4 |a Urothelial carcinoma 
700 1 |a Nagy, Anetta  |e VerfasserIn  |0 (DE-588)1156311527  |0 (DE-627)1018864245  |0 (DE-576)502100729  |4 aut 
700 1 |a Kovacs, Gyula  |e VerfasserIn  |0 (DE-588)1081747579  |0 (DE-627)846587424  |0 (DE-576)454756399  |4 aut 
773 0 8 |i Enthalten in  |t Anticancer research  |d Kapandriti, Attiki, Greece : International Institute of Anticancer Research, 2004  |g 32(2012), 2, Seite 523-527  |h Online-Ressource  |w (DE-627)387478493  |w (DE-600)2145376-7  |w (DE-576)358408717  |x 1791-7530  |7 nnas  |a P53 mutation and LOH at chromosome 9 in urothelial carcinoma 
773 1 8 |g volume:32  |g year:2012  |g number:2  |g pages:523-527  |g extent:5  |a P53 mutation and LOH at chromosome 9 in urothelial carcinoma 
856 4 0 |u http://ar.iiarjournals.org/content/32/2/523  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180418 
993 |a Article 
994 |a 2012 
998 |g 1081747579  |a Kovacs, Gyula  |m 1081747579:Kovacs, Gyula  |d 910000  |d 910200  |e 910000PK1081747579  |e 910200PK1081747579  |k 0/910000/  |k 1/910000/910200/  |p 4  |y j 
998 |g 1156311527  |a Nagy, Anetta  |m 1156311527:Nagy, Anetta  |d 910000  |d 910200  |e 910000PN1156311527  |e 910200PN1156311527  |k 0/910000/  |k 1/910000/910200/  |p 2 
998 |g 1156311438  |a Beöthe, Tamás  |m 1156311438:Beöthe, Tamás  |d 910000  |d 910200  |e 910000PB1156311438  |e 910200PB1156311438  |k 0/910000/  |k 1/910000/910200/  |p 1  |x j 
999 |a KXP-PPN1572106344  |e 3006334647 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Tamás","family":"Beöthe","role":"aut","display":"Beöthe, Tamás","roleDisplay":"VerfasserIn"},{"family":"Nagy","given":"Anetta","roleDisplay":"VerfasserIn","display":"Nagy, Anetta","role":"aut"},{"role":"aut","display":"Kovacs, Gyula","roleDisplay":"VerfasserIn","given":"Gyula","family":"Kovacs"}],"title":[{"title":"P53 mutation and LOH at chromosome 9 in urothelial carcinoma","title_sort":"P53 mutation and LOH at chromosome 9 in urothelial carcinoma"}],"recId":"1572106344","language":["eng"],"note":["Gesehen am 18.04.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Tamas Beothe, Anetta Nagy, Laszlo Farkas, Gyula Kovacs"]},"id":{"eki":["1572106344"]},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"December 21, 2011"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["International Institute of Anticancer Research"]},"id":{"issn":["1791-7530"],"zdb":["2145376-7"],"eki":["387478493"]},"origin":[{"publisherPlace":"Kapandriti, Attiki, Greece","dateIssuedKey":"2004","publisher":"International Institute of Anticancer Research","dateIssuedDisp":"2004-"}],"recId":"387478493","language":["eng"],"disp":"P53 mutation and LOH at chromosome 9 in urothelial carcinomaAnticancer research","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 26.02.13"],"part":{"text":"32(2012), 2, Seite 523-527","volume":"32","extent":"5","year":"2012","issue":"2","pages":"523-527"},"pubHistory":["Nachgewiesen 24.2004 -"],"title":[{"title":"Anticancer research","subtitle":"international journal of cancer research and treatment","title_sort":"Anticancer research"}]}],"physDesc":[{"extent":"5 S."}]} 
SRT |a BEOETHETAMP53MUTATIO2120